Authors:
Citrome, L
Volavka, J
Czobor, P
Sheitman, B
Lindenmayer, JP
McEvoy, J
Cooper, TB
Chakos, M
Lieberman, JA
Citation: L. Citrome et al., Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia, PSYCH SERV, 52(11), 2001, pp. 1510-1514
Authors:
Lindenmayer, JP
Volavka, J
Lieberman, J
Sheitman, B
Citrome, L
Chakos, M
Czobor, P
Parker, B
Iskander, A
Citation: Jp. Lindenmayer et al., Olanzapine for schizophrenia refractory to typical and atypical antipsychotics: An open-label, prospective trial, J CL PSYCH, 21(4), 2001, pp. 448-453
Authors:
Sheitman, BB
Murray, MG
Snyder, JA
Silva, S
Goldman, R
Chakos, M
Volavka, J
Lieberman, JA
Citation: Bb. Sheitman et al., IQ scores of treatment-resistant schizophrenia patients before and after the onset of the illness, SCHIZOPHR R, 46(2-3), 2000, pp. 203-207
Authors:
Hallikainen, T
Lachman, H
Saito, T
Volavka, J
Kauhanen, J
Salonen, JT
Ryynanen, OP
Koulu, M
Karvonen, MK
Pohjalainen, T
Syvalahti, E
Hietala, J
Tiihonen, J
Citation: T. Hallikainen et al., Lack of association between the functional variant of the catechol-o-methyltransferase (COMT) gene and early-onset alcoholism associated with severe antisocial behavior, AM J MED G, 96(3), 2000, pp. 348-352
Authors:
Hallikainen, T
Saito, T
Lachman, HM
Volavka, J
Pohjalainen, T
Ryynanen, OP
Kauhanen, J
Syvalahti, E
Hietala, J
Tiihonen, J
Citation: T. Hallikainen et al., Association between low activity serotonin transporter promoter genotype and early onset alcoholism with habitual impulsive violent behavior, MOL PSYCHI, 4(4), 1999, pp. 385-388
Authors:
Tiihonen, J
Hallikainen, T
Lachman, H
Saito, T
Volavka, J
Kauhanen, J
Salonen, JT
Ryynanen, OP
Koulu, M
Karvonen, MK
Pohjalainen, T
Syvalahti, E
Hietala, J
Citation: J. Tiihonen et al., Association between the functional variant of the catechol-O-methyltransferase (COMT) gene and type 1 alcoholism, MOL PSYCHI, 4(3), 1999, pp. 286-289
Citation: Ka. Nolan et al., Psychopathy and violent behavior among patients with schizophrenia or schizoaffective disorder, PSYCH SERV, 50(6), 1999, pp. 787-792
Citation: J. Volavka et L. Citrome, Atypical antipsychotics in the treatment of the persistently aggressive psychotic patient: methodological concerns, SCHIZOPHR R, 35, 1999, pp. S23-S33
Citation: Wt. Carpenter et al., Dopamine, receptor occupancy and the action of clozapine: Does it make a difference to add a neuroleptic? Reply, BIOL PSYCHI, 46(1), 1999, pp. 147-149